Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-03Clinical Trial Update: A Master Protocol Study to Investigate Biomarker-guided Novel Anticancer Agent(s) as Monotherapy or Combination Therapy in Participants With Advanced/Recurrent Ovarian Cancer [Phase 1, Phase 2]
A master protocol Phase 1/2 trial sponsored by AstraZeneca evaluating biomarker-guided anticancer agents for advanced/recurrent ovarian canc…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O) [NA]
The POSTCARE-O study, sponsored by Baylor College of Medicine, is recruiting to evaluate survivorship care for women with ovarian cancer, fo…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Extended Versus Short Prehabilitation Programme for Patients With Advanced Ovarian Cancer Undergoing Major Surgery [NA]
This clinical trial entry describes a study comparing extended versus short prehabilitation before major surgery in patients with advanced o…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
Phase 1 trial evaluating a carboplatin/gemcitabine hydrochloride/berzosertib combination in patients with recurrent or metastatic ovarian, f…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas [Phase 2]
Clinical trial BrUOG 354 assesses nivolumab with or without ipilimumab in ovarian and extrarenal (clear cell) carcinomas; the Phase 2 study …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer [Phase 1]
FT536 is being evaluated in a Phase 1 trial for recurrent ovarian cancer, fallopian tube cancer, and primary peritoneal cancer, and the stud…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
Clinical trial update for a Phase 1 drug-drug interaction study evaluating AZD5335 with itraconazole in ovarian-, fallopian tube-, or primar…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Patent Blue SLN in Early Ovarian Cancer Prospective Study (FIGO I-II) Evaluating Patent Blue SLN Mapping. Injection Into IP/UO Ligaments in Situ. Goals: Assess Feasibility and Accuracy vs Standard Lymphadenectomy to Minimize Surgical Morbidity
A prospective study in early-stage ovarian cancer is evaluating the feasibility and accuracy of Patent Blue SLN mapping versus standard lymp…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib [Phase 2]
A Phase II trial evaluating nivolumab, bevacizumab, and rucaparib in peritoneal cancer, ovarian cancer, and fallopian tube cancer; results h…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer [Phase 2]
Phase 2 trial evaluating oregovomab in combination with chemotherapy in the neoadjuvant setting for newly diagnosed advanced epithelial ovar…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery [Phase 2]
Phase 2 clinical trial update on acute normovolemic hemodilution in patients with ovarian cancer undergoing cytoreductive surgery; currently…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery [Phase 3]
A Phase 3 trial of oregovomab plus chemotherapy for newly diagnosed advanced epithelial ovarian cancer after optimal debulking surgery is cu…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety and efficacy of COM701 in relapsed platinum-sensitive ovarian cancer is currently recruitin…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Using Aspirin to Improve Immunological Features of Ovarian Tumors [EARLY_Phase 1]
Phase 1 trial is exploring whether aspirin can improve the immunological features of ovarian tumors and related cancers. The study is curren…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer [Phase 1, Phase 2]
Open-label Phase 1/2 trial update evaluating INX-315 in patients with advanced cancers, including breast and ovarian cancer, with recruitmen…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Survivors Uniting for Remote Guided Exercise [NA]
Clinical trial update from Colorado State University about a remote guided exercise program for cancer survivors; the study is currently rec…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers [Phase 1]
Phase 1 study of AB598 as monotherapy and in combination across multiple advanced cancers is ongoing, with status active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours) [Phase 1]
A Phase 1 trial to assess tolerability of different doses of BI 3820768 in adults with advanced relapsed or refractory germ cell tumors, end…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Predictive Clinical and Biological Parameters in Gynecological Cancer [NA]
Ongoing study evaluating predictive clinical and biological parameters across gynecologic cancers (ovarian, endometrial, and cervical cancer…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: DESTINY-PANTUMOUR04
Clinical trial update for the DESTINY-PANTUMOUR04 study sponsored by AstraZeneca, evaluating trastuzumab deruxtecan across multiple cancer t…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Ovarian Cancer Screening and AI [NA]
This clinical trial update describes a study evaluating the use of artificial intelligence to inform ovarian cancer screening recommendation…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer [Phase 1]
Phase 1 study to evaluate NMS-03305293 in adults with relapsed ovarian cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer [Phase 1]
This Clinical Trials Update describes a Phase 1 study of an Fc-engineered anti-CTLA-4 monoclonal antibody by Agenus in patients with advance…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: SurgiPerito Trial: High-Purity Type-I Collagen for Peritoneal Reconstruction After Cytoreductive Surgery [NA]
Completed a clinical trial evaluating high-purity Type-I collagen for peritoneal reconstruction after cytoreductive surgery. The trial targe…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors [Phase 1]
Phase 1 trial update on the safety of RAD301 in healthy volunteers and patients with pancreatic ductal adenocarcinoma or other solid tumors;…